Cargando…
Phaeochromocytomas/paragangliomas and adverse clinical outcomes in patients with Neurofibromatosis type 1
INTRODUCTION: Phaeochromocytomas/paragangliomas (PHAEO/PG) are linked to hereditary syndromes including Neurofibromatosis type 1 (NF-1). Current guidelines do not recommend biochemical screening for PHAEO/PG in asymptomatic or normotensive patients with NF-1. This strategy may miss preventable morbi...
Autores principales: | Al-Sharefi, A, Perros, P, James, R A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198184/ https://www.ncbi.nlm.nih.gov/pubmed/30120202 http://dx.doi.org/10.1530/EC-18-0208 |
Ejemplares similares
-
Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1
por: Al-Sharefi, Ahmed, et al.
Publicado: (2019) -
The clinical genetics of phaeochromocytoma and paraganglioma
por: Kavinga Gunawardane, P. T., et al.
Publicado: (2017) -
Predictors of outcome in phaeochromocytomas and paragangliomas
por: Nicolas, Marlo, et al.
Publicado: (2017) -
Precision Medicine in Phaeochromocytoma and Paraganglioma
por: Winzeler, Bettina, et al.
Publicado: (2021) -
A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma
por: Boot, Christopher S.
Publicado: (2023)